Enanta Pharmaceuticals
ENTA
#7360
Rank
NZ$0.77 B
Marketcap
NZ$26.73
Share price
5.92%
Change (1 day)
140.53%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$0.11 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has NZ$0.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$NZ$0.20 B-43.85%
2023-09-30$NZ$0.36 B-36.58%
2022-09-30$NZ$0.57 B-1.57%
2021-09-30$NZ$0.57 B-15.81%
2020-09-30$NZ$0.68 B-6.86%
2019-09-30$NZ$0.73 B24.26%
2018-09-30$NZ$0.59 B41.69%
2017-09-30$NZ$0.41 B12.82%
2016-09-30$NZ$0.37 B0.59%
2015-09-30$NZ$0.36 B94.17%
2014-09-30$NZ$0.19 B42.95%
2013-09-30$NZ$0.13 B150.95%
2012-09-30$NZ$53.06 M85.51%
2011-09-30$NZ$28.6 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AbbVie
ABBV
-NZ$4.52 Billion-4,115.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$137.68 B 122,397.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$30.07 B 26,660.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$90.14 B 80,106.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.30 B 28,640.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$77.72 B 69,050.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland